These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Antibody responses to lipid A, core, and O sugars of the Pseudomonas aeruginosa lipopolysaccharide in chronically infected cystic fibrosis patients. Kronborg G, Fomsgaard A, Galanos C, Freudenberg MA, Høiby N. J Clin Microbiol; 1992 Jul; 30(7):1848-55. PubMed ID: 1378455 [Abstract] [Full Text] [Related]
3. Quantitative analysis of the IgG and IgG subclass immune responses to chromosomal Pseudomonas aeruginosa beta-lactamase in serum from patients with cystic fibrosis by western blotting and laser scanning densitometry. Petersen TD, Ciofu O, Pressler T, Giwercman B, Pedersen SS, Høiby N. Thorax; 1996 Jul; 51(7):733-8. PubMed ID: 8882082 [Abstract] [Full Text] [Related]
4. Immunoglobulin-G subclasses in cystic fibrosis. IgG2 response to Pseudomonas aeruginosa lipopolysaccharide. Fick RB, Olchowski J, Squier SU, Merrill WW, Reynolds HY. Am Rev Respir Dis; 1986 Mar; 133(3):418-22. PubMed ID: 3082264 [Abstract] [Full Text] [Related]
5. Anti-Pseudomonas aeruginosa IgG subclass titers in patients with cystic fibrosis: correlations with pulmonary function, neutrophil chemotaxis, and phagocytosis. Cowan RG, Winnie GB. J Clin Immunol; 1993 Sep; 13(5):359-70. PubMed ID: 8245182 [Abstract] [Full Text] [Related]
6. Association with phagocytic inhibition of anti-Pseudomonas aeruginosa immunoglobulin G antibody subclass levels in serum from patients with cystic fibrosis. Shryock TR, Mollé JS, Klinger JD, Thomassen MJ. J Clin Microbiol; 1986 Mar; 23(3):513-6. PubMed ID: 3082922 [Abstract] [Full Text] [Related]
8. Study of IgG antibodies to Pseudomonas aeruginosa in early cystic fibrosis infection. Giordano A, Magni A, Filadoro F, Graziani C, Quattrucci S, Cipriani P. New Microbiol; 1998 Oct; 21(4):375-8. PubMed ID: 9812319 [Abstract] [Full Text] [Related]
9. Longitudinal study of antibody response to lipopolysaccharides during chronic Pseudomonas aeruginosa lung infection in cystic fibrosis. Fomsgaard A, Høiby N, Shand GH, Conrad RS, Galanos C. Infect Immun; 1988 Sep; 56(9):2270-8. PubMed ID: 3410536 [Abstract] [Full Text] [Related]
10. IgG subclass antibody responses to alginate from Pseudomonas aeruginosa in patients with cystic fibrosis and chronic P. aeruginosa infection. Pressler T, Pedersen SS, Espersen F, Høiby N, Koch C. Pediatr Pulmonol; 1992 Sep; 14(1):44-51. PubMed ID: 1437343 [Abstract] [Full Text] [Related]
11. IgG subclasses and chronic bacterial infection. Subclass antibodies and the clinical course of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis. Pressler T. APMIS Suppl; 1996 Sep; 66():1-41. PubMed ID: 8972694 [No Abstract] [Full Text] [Related]
15. Increased levels of IgG subclasses specific for Pseudomonas aeruginosa exoenzyme and polysaccharide antigens in chronically infected patients with cystic fibrosis. Albus A, Saalmann M, Tesch H, Pedersen SS, Döring G. APMIS; 1989 Dec; 97(12):1146-8. PubMed ID: 2482060 [Abstract] [Full Text] [Related]
16. Serotype-specific serum IgG antibodies to lipopolysaccharides of Pseudomonas aeruginosa in cystic fibrosis: correlation to disease, subclass distribution, and experimental protective capacity. Schaad UB, Lang AB, Wedgwood J, Buehlamnn U, Fuerer E. Pediatr Res; 1990 May; 27(5):508-13. PubMed ID: 2111907 [Abstract] [Full Text] [Related]
19. Assessment of IgG antibodies to Pseudomonas aeruginosa in patients with cystic fibrosis by an enzyme-linked immunosorbent assay (ELISA). Mauch RM, Rossi CL, Ribeiro JD, Ribeiro AF, Nolasco da Silva MT, Levy CE. Diagn Pathol; 2014 Aug 22; 9():158. PubMed ID: 25146522 [Abstract] [Full Text] [Related]